Actos News and Information Updates for June

The Actos lawyers at the Firm are diligently monitoring information about the type 2 diabetes drug, Actos.  We encourage you to learn more about the serious side effects, risks and legal options surrounding Actos.

  • The Link Between the Diabetes Drug Actos and Bladder Cancer
    In the U.S., bladder cancer is relatively uncommon. However, in 2012, 75,310 new cases were diagnosed according to the American Cancer Society. New research suggests that the risk for bladder cancer may double in patients using the Actos drug to treat diabetes for more than two years.
  • The Risk of Getting Cancer May Increase Due to Diabetes Drug Actos
    According to US News Health, patients taking Actos to treat type 2 diabetes may be putting themselves at risk for bladder cancer. While experts believe the absolute risk of developing bladder cancer is very low, taking Actos may double the risk for patients.
  • Diabetes Drug Increases Risk of Bladder Cancer
    A group of Montreal researchers are reporting that Actos users are two times as likely to develop bladder cancer as people who don’t. After being on the type 2 diabetes drug for more than two years, the risk of bladder cancer doubles. This drug is meant to be taken long term and its generic counterpoint is called pioglitazone.
  • Recent Studies Affirm Bladder Cancer Risk Associated with Actos
    According to recent studies, there is a correlation between the Actos type 2 diabetes drug and an increased risk of bladder cancer. Patients with type 2 diabetes who were treated with Actos had an 83% higher risk for bladder cancer than those who were never on the drug.


Simmons Support Team
Simmons Hanly ConroyWritten by:

Editorial Team

The Simmons Hanly Conroy Editorial Team consists of journalists, writers and editors who strive to deliver accurate and useful information to families needing legal help. Our team works alongside the firm's attorneys and partners, as well as with medical professionals and other specialists, to keep all information relevant and helpful.